|
| Status |
Public on Oct 16, 2021 |
| Title |
Identification of pharmacologic inhibitors and activators of IL-4-induced macrophage polarization [PBMC ChIP-seq] |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
Macrophages polarize towards different subpopulations with distinct and partly antagonistic functions in various diseases. IFNγ/LPS-polarized M1-type macrophages can have antiangiogenic activity, whereas IL-4-induced M2-type macrophages can be proangiogenic and profibrotic. Therapeutic strategies to inhibit M2-type polarization while promoting M1-type polarization could serve to inhibit pathological angiogenesis and fibrosis. Here, by combining global quantitative time-course proteomics and phosphoproteomics with a small-molecule inhibitor screen we identify signaling events that promote specifically IL-4-induced and not IFNγ/LPS-induced macrophage polarization and found that the MEK inhibitor trametinib and the HDAC inhibitor panobinostat potently prevent M2-type macrophage polarization without inhibiting M1-type polarization. In contrast, selective B-Raf inhibition promotes M2-type polarization. Trametinib and panobinostat also blocked M2-type macrophage polarization and concomitantly angiogenesis and fibrosis in models of wound healing and neovascular age-related macular degeneration in vivo. Thus, these pharmacologic inhibitors could be utilized therapeutically to selectively block IL4-induced macrophage polarization and reduce pathologic angiogenesis and fibrosis.
|
| |
|
| Overall design |
PBMC ChIP-seq
|
| |
|
| Contributor(s) |
He L, Marneros AG |
| Citation(s) |
34731634 |
| |
| Submission date |
Jul 13, 2020 |
| Last update date |
Dec 31, 2021 |
| Contact name |
Alexander G Marneros |
| E-mail(s) |
[email protected]
|
| Organization name |
Massachusetts General Hospital, Harvard Medical School
|
| Department |
Department of Dermatology, Cutaneous Biology Research Center
|
| Street address |
13th Street
|
| City |
Charlestown |
| State/province |
MA |
| ZIP/Postal code |
02129 |
| Country |
USA |
| |
|
| Platforms (1) |
|
| Samples (18)
|
|
| This SubSeries is part of SuperSeries: |
| GSE154347 |
Identification of pharmacologic inhibitors and activators of IL-4-induced macrophage polarization in PBMC and THP-1 cells |
|
| Relations |
| BioProject |
PRJNA645923 |
| SRA |
SRP271637 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE154342_PBMC_CTRL_DMSO_R1.mLb.clN.bigWig |
337.7 Mb |
(ftp)(http) |
BIGWIG |
| GSE154342_PBMC_CTRL_DMSO_R1_summits.bed.gz |
1.2 Mb |
(ftp)(http) |
BED |
| GSE154342_PBMC_CTRL_PANO_R1.mLb.clN.bigWig |
214.7 Mb |
(ftp)(http) |
BIGWIG |
| GSE154342_PBMC_CTRL_PANO_R1_summits.bed.gz |
800.2 Kb |
(ftp)(http) |
BED |
| GSE154342_PBMC_IFN_DMSO_R1.mLb.clN.bigWig |
361.0 Mb |
(ftp)(http) |
BIGWIG |
| GSE154342_PBMC_IFN_DMSO_R1_summits.bed.gz |
881.9 Kb |
(ftp)(http) |
BED |
| GSE154342_PBMC_IFN_PANO_R1.mLb.clN.bigWig |
323.0 Mb |
(ftp)(http) |
BIGWIG |
| GSE154342_PBMC_IFN_PANO_R1_summits.bed.gz |
933.9 Kb |
(ftp)(http) |
BED |
| GSE154342_PBMC_IL4_DMSO_R1.mLb.clN.bigWig |
301.6 Mb |
(ftp)(http) |
BIGWIG |
| GSE154342_PBMC_IL4_DMSO_R1_summits.bed.gz |
956.1 Kb |
(ftp)(http) |
BED |
| GSE154342_PBMC_IL4_PANO_R1.mLb.clN.bigWig |
430.3 Mb |
(ftp)(http) |
BIGWIG |
| GSE154342_PBMC_IL4_PANO_R1_summits.bed.gz |
869.3 Kb |
(ftp)(http) |
BED |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data are available on Series record |
Less...
More...